Reply to: Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study” and a case report of glucagon-like peptide-1 receptor agonist induced bullous pemphigoid

Publication date: Available online 7 February 2019

Source: Journal of the American Academy of Dermatology

Author(s): O. Varpuluoma, K. Tasanen, L. Huilaja

http://bit.ly/2SiFZsD